Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 3 1

Status

Completed 20Unknown 10Terminated 7Active not recruiting 6Recruiting 4Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 4Gastrointestinal 2

Conditions

Multiple Myeloma 3Stomach Neoplasms 1Recurrence 1Pseudomyxoma Peritonei 1Neoplasms, Plasma Cell 1Atrophy 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Clarithromycin × Clear all
NCT04302324 2026-05-20

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab

Weill Medical College of Cornell University

Phase 2 Active not recruiting
11 enrolled 15 charts
Plasma cell

Multiple Myeloma

NCT02343042 2026-05-04

STOMP

Karyopharm Therapeutics Inc

Phase 1/2 Active not recruiting
300 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT01559935 2025-09-08

CarBiRD

Weill Medical College of Cornell University

Phase 2 Active not recruiting
74 enrolled 12 charts
Plasma cell

Multiple Myeloma

NCT02387203 2024-11-19

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Mercy Medical Center

Phase 2 Active not recruiting
80 enrolled
Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

NCT02542657 2024-09-19

Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma

University of California, Davis

Phase 1/2 Active not recruiting
30 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT02407119 2023-11-09

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

National Cancer Center, Korea

Phase 3 Active not recruiting
470 enrolled
Gastrointestinal

Atrophy, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡